Healthcare


 Medlab Clinical signs HoA with Pharmascience Inc for NanaBis

Medlab Clinical signs HoA with Pharmascience Inc for NanaBis

March 05, 2019 08:02 PM AEDT| By Team Kalkine Media

Medlab Clinical Limited (ASX: MDC), established in 2012, is an Alexandria, Australia-based medical life science company engaged in research and development of nutraceutical products and therapeutic pathways for diagnosed chronic diseases such as pain...

 Imugene released Presentation on KEY-Vaxx and B-Vaxx Cancer Vaccine Programs for the 2019 AACR

Imugene released Presentation on KEY-Vaxx and B-Vaxx Cancer Vaccine Programs for the 2019 AACR

March 04, 2019 06:47 PM AEDT| By Team Kalkine Media

Imugene Limited (ASX: IMU) is a biotechnology company with operations in America and Europe. The company is into the development of biologic therapies for the treatment of cancer while targeting the B-cell peptide vaccines. Among its key vaccines inc...

 3 Hot Biotech Stocks – Impression Healthcare, Orthocell And Althea

3 Hot Biotech Stocks – Impression Healthcare, Orthocell And Althea

March 02, 2019 09:15 AM AEDT| By Team Kalkine Media

Impression Healthcare Limited (ASX: IHL) Dental services provider, Impression Healthcare Limited recently executed an exclusivity agreement with RespireRx for the use of Dronabinol for Obstructive Sleep Apnoea in New Zealand, Australia and SE Asia....

 Imugene’s Shares zoomed up by 17.65% on the declaration of Half-year results

Imugene’s Shares zoomed up by 17.65% on the declaration of Half-year results

February 28, 2019 11:00 PM AEDT| By Team Kalkine Media

Imugene Limited (ASX: IMU) has released its half-year results ended 31 December 2018. As at 31 December 2018, the group recorded a loss for half-year $3,449,097 (2017: $1,632,852). The loss in the business from the comparative period was caused by th...

 Paragon Care’s Shares Slipped Post The Announcement Of 1H FY19 Results

Paragon Care’s Shares Slipped Post The Announcement Of 1H FY19 Results

February 28, 2019 04:59 PM AEDT| By Team Kalkine Media

Paragon Care Limited (ASX: PGC) has announced its half-yearly report for the financial year 2019. It reported approximately 9% organic growth achieved in 1H FY2019 from its continuing business. Its gross margin for 1H FY2019 stood at around 38%. It r...

 Ramsay Healthcare releases first results after Capio acquisition, 1HFY19 revenue up 16.3%

Ramsay Healthcare releases first results after Capio acquisition, 1HFY19 revenue up 16.3%

February 28, 2019 03:36 PM AEDT| By Team Kalkine Media

Healthcare sector giant, Ramsay Healthcare Limited (ASX: RHC) witnesses the bullish market trends after the company announced higher Core Net Profit After Tax of $290.8 million for the half-year ended 31 December 2018, up 1.0% on the previous corresp...

 Capitol Health Share Price Plunged 23.4% Post-Half-year Results Announcement

Capitol Health Share Price Plunged 23.4% Post-Half-year Results Announcement

February 27, 2019 08:15 PM AEDT| By Team Kalkine Media

Capitol Health Limited (ASX: CAJ) announced its half-year results for the period 1 July 2018 through 31 December 2018. Financial performance: During the period the Company delivered revenue of $72.9m (up $16.8m or ~30% compared to prior correspond...

 Starpharma Shares Tumbled On ASX With Reported Loss Growing By ~17.0% In 1HFY19

Starpharma Shares Tumbled On ASX With Reported Loss Growing By ~17.0% In 1HFY19

February 27, 2019 04:44 PM AEDT| By Team Kalkine Media

Starpharma Holdings Limited (ASX: SPL) is into the development of dendrimer products for pharmaceutical, life-science and other applications. The dendrimer is a type of synthetic nanoscale polymer that is used for pharmaceutical and medical uses. Viv...

 Imugene Reported Cancer Research Publishing In The Prestigious American Journal

Imugene Reported Cancer Research Publishing In The Prestigious American Journal

February 26, 2019 09:57 PM AEDT| By Team Kalkine Media

Imugene Limited (ASX: IMU), which is in the business of clinical stage immuno-oncology, IS building up a range of new and novel immunotherapies that try to activate the immune system of malignancy patients to treat tumors. The company?s extraordinary...

 3 Hot Biotech Stocks On Discussion Radar - BOT, MVF And NUH

3 Hot Biotech Stocks On Discussion Radar - BOT, MVF And NUH

February 26, 2019 09:02 PM AEDT| By Team Kalkine Media

Botanix Pharmaceuticals Ltd Botanix Pharmaceuticals Limited (ASX: BOT) is a Northbridge, Australia-based clinical stage medical dermatology company that develops safe and effective therapeutic treatment, for serious skin diseases, such as transderma...

 Estia Health Distributes ~100% Of Profit To Shareholders For The First Half Of Fiscal 2019

Estia Health Distributes ~100% Of Profit To Shareholders For The First Half Of Fiscal 2019

February 26, 2019 07:00 PM AEDT| By Team Kalkine Media

Australia?s leading aged care service provider, Estia Health Limited (ASX: EHE) unleashed the robust performance of its first half of Fiscal 2019 with EBITDA up 3.1% to $46.9 million, NPAT of $21.1 million up 4.1%, and Revenue up 6.6% to $289.7 milli...

 A Shot In The Arm For MGC Pharma, Independent Laboratory Test Validates Proprietary Genetic Strains!

A Shot In The Arm For MGC Pharma, Independent Laboratory Test Validates Proprietary Genetic Strains!

February 26, 2019 03:03 PM AEDT| By Team Kalkine Media

EU based MGC Pharmaceuticals Ltd (ASX: MXC) has received independent verification of its premium grade THC and CBD genetic strains, and with that, the strains are now registered with the EU. Slovenia based University of Ljubljana Biotechnical Faculty...

 Auscann Appointed Mr Ido Kanyon As Its CEO – Stock Zoomed Up By 2.353% 

Auscann Appointed Mr Ido Kanyon As Its CEO – Stock Zoomed Up By 2.353% 

February 26, 2019 02:54 PM AEDT| By Team Kalkine Media

AusCann Group Holdings Ltd (ASX: AC8), a company from the health care sector engaged into cultivation, manufacture and supply of medical cannabis products, has announced the appointment of global pharmaceutical business executive, Mr Ido Kanyon as a...

 Blackmores’ Shares Tumbled on ASX after Announcing the Resignation of its CEO

Blackmores’ Shares Tumbled on ASX after Announcing the Resignation of its CEO

February 26, 2019 10:58 AM AEDT| By Team Kalkine Media

Australia?s leading natural health company, Blackmores Limited (ASX: BKL) has announced the resignation of its Chief Executive Officer (CEO), Mr. Richard Henfrey. Following this news, the share price of the company decreased by 3.918% as on 26 Februa...

 Nanosonics Witnessed A 12% Jump On ASX On Releasing 1HFY2019 Financial Results

Nanosonics Witnessed A 12% Jump On ASX On Releasing 1HFY2019 Financial Results

February 25, 2019 05:08 PM AEDT| By Team Kalkine Media

Healthcare company, Nanosonics Limited (ASX: NAN) has published its Half Yearly Report for the half year ending 31 December 2018. Business Performance The sales for the period stood at $40,693,000, as compared to the sales of $30,009,000 were noted...

 Japara Healthcare Declared Business Results For H1 FY2019

Japara Healthcare Declared Business Results For H1 FY2019

February 25, 2019 03:49 PM AEDT| By Team Kalkine Media

Japara Healthcare Limited (ASX: JHC), based in Southbank, along with its subsidiaries owns, develops, and operates around 5,400 residential aged care facilities across 48 homes located in Queensland, Victoria, South Australia, New South Wales, and Ta...

 All That Investors Need To Know About 1HFY19 Results Reported By BWX Limited

All That Investors Need To Know About 1HFY19 Results Reported By BWX Limited

February 25, 2019 03:07 PM AEDT| By Team Kalkine Media

On 22nd February 2019, BWX Limited (ASX: BWX) which is in the business of making branded products of the body, hair and skin care industry with some popular brands like Derma Sukin, Sukin, Uspa and many more, announced its 1H19 results. The company...

 Monash IVF Group Releases Its Half Year Results For FY 2019

Monash IVF Group Releases Its Half Year Results For FY 2019

February 25, 2019 02:00 PM AEDT| By Team Kalkine Media

Monash IVF Group Limited (ASX: MVF) develops assisted reproductive technologies (ART) and tertiary level prenatal diagnostics, and it provides a complete range of specialist diagnostic obstetric and gynaecological ultrasound and fertility treatments...

 Growth Scenario For The 2 Healthcare Stocks- RMD And MYX

Growth Scenario For The 2 Healthcare Stocks- RMD And MYX

February 23, 2019 09:45 AM AEDT| By Team Kalkine Media

Resmed Inc The Bella Vista, Australia-based ResMed Inc (ASX: RMD) is a company established in 1994 and engaged in the development, production, and commercialization of medical devices and cloud-based software applications that diagnose, treat and ma...

 A Quick look on Anatara Lifesciences’ Gastrointestinal ReProgramming progress

A Quick look on Anatara Lifesciences’ Gastrointestinal ReProgramming progress

February 22, 2019 10:11 PM AEDT| By Team Kalkine Media

Health care sector company Anatara Lifesciences Ltd (ASX: ANR) unveiled the favourable results from its in-vitro proof of concept study of its first human product candidate, Gastrointestinal ReProgramming (GaRP). Anatara is an Australia-based life s...

AU_advertise

Advertise your brand on Kalkine Media

Recent Articles






Investing Tips

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.